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Available online 29 September 2011A clever and effective idea from the Karolinska Institute in
Stockholm, Sweden, with collaborations between a center
of Molecular Medicine and the clinical divisions of Surgery
and Internal Medicine, generated this paper, capitalising on
an interesting project generating a “bio-bank” (BIKE) of
gene expression profiles and clinical information from 106
patients undergoing carotid endarterectomy (CE).
This paper may seem quite complex to grasp, especially
for a vascular surgery readership, since it analyzes a large
amount of data without any clear hypothesis testing.
Therefore the reader needs to refer to the lengthy supple-
mentary data, in order to understand the results. However,
the effort of the authors’ in the microarray gene analysis on
more than 100 CE specimens has to be applauded.
Gene expression profiling is the measurement of the
activity (the expression) of thousands of genes at once, to
create a global picture of cellular and tissue functions. For
this purpose, the authors utilized the DNA Microarray
technology that measures the relative activity of previously
identified target genes.
Therefore, the authors “chose a biased approach and
limited the genes studied to 317 candidates already thought
to be associated with plaque instability or healing processes
in the vessel wall, and correlated the gene expression anal-
ysis to clinical parameters”. The number of genes and the
several clinical subgroups analyzed make statistical signifi-
cant conclusions difficult to reach for any clinical translation.DOI of original article: 10.1016/j.ejvs.2011.05.023.
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doi:10.1016/j.ejvs.2011.06.045Changes in the analyzed gene expression are in accor-
dance with previously published papers showing an upre-
gulation of genes involved in matrix degradation and
inflammatory pathways in atherosclerotic plaque tissue vs
control, symptomatic versus asymptomatic, statin
untreated versus treated, echolucent versus ecodense
plaque, MS or TIA versus AF and vice versa. From this point
of view, microarray analysis is confirming the different
approaches of previous studies, without giving new insights
in the comprehension of plaque instability.
However there is new insight into the timing of gene
expression. It is surprising that lesions removed early after
symptoms (within 15 days) of plaque instability are char-
acterized by less inflammation and proteolysis, with various
smooth muscle cellmarker genes being increased and
macrophage but T-cell marker genes levels decreased. Even
more surprisingly, plaques removed at a later time point
(more than 1 month) after symptoms, showed increased
expression of genes involved in inflammatory processes and
matrix degradation. This timing of “unhealthy changes in
gene expression” contrasts with the clinical evidence of
higher risk of cerebrovascular events in the first 2 weeks
after index symptoms.
The authors’ offer a sound final conclusion, that their
bio-bank platform could be used in the future to explore
new unknown mediators and pathways of carotid plaque
instability and healing. To reach this future goal, it may be
interesting to use the serial analysis of gene expression
(SAGE) technique, which is a sequence-based sampling
technique not based on hybridization, so that the mRNA
sequences do not need to be known a priori and novel
genes and gene variants, not yet known, can be discovered.Society for Vascular Surgery.
